Inhibikase Therapeutics, Inc.
IKT
$1.44
$0.032.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2,283.84% | 1,004.10% | 855.75% | 636.06% | -80.73% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 132.04% | 98.37% | 9.79% | 8.43% | -26.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -10.12% | 42.23% | -66.65% | -51.64% | 85.32% |
| Total Current Assets | 1,774.34% | 932.16% | 771.27% | 592.78% | -76.13% |
|
|
|||||
| Total Current Assets | 1,774.34% | 932.16% | 771.27% | 592.78% | -76.13% |
| Net Property, Plant & Equipment | -100.00% | -73.84% | -55.21% | -49.76% | -43.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,718.51% | 906.63% | 751.83% | 579.69% | -75.52% |
|
|
|||||
| Total Accounts Payable | -75.47% | 101.69% | 30.79% | 45.79% | 244.30% |
| Total Accrued Expenses | 69.17% | 54.63% | 40.10% | 18.58% | 16.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -75.10% | -50.53% | -26.38% | -2.55% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 36.45% | 137.54% | 102.00% | 8.58% | 78.99% |
|
|
|||||
| Total Current Liabilities | 36.45% | 137.54% | 102.00% | 8.58% | 78.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 36.45% | 135.91% | 99.25% | 5.81% | 71.42% |
|
|
|||||
| Common Stock & APIC | 148.11% | 142.71% | 147.46% | 143.10% | 5.16% |
| Retained Earnings | -57.92% | -54.25% | -51.08% | -41.14% | -31.19% |
| Treasury Stock & Other | -333.33% | -190.00% | 44.44% | -4,233.33% | 1,900.00% |
| Total Common Equity | 13,838.84% | 1,470.73% | 1,165.08% | 764.16% | -103.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13,838.84% | 1,470.73% | 1,165.08% | 764.16% | -103.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13,838.84% | 1,470.73% | 1,165.08% | 764.16% | -103.53% |
|
|
|||||